| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.2 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, was found in Scriptme SmE GB Host 1.21. Affected by this vulnerability is an unknown functionality. Such manipulation leads to cross site scripting. This vulnerability is listed as CVE-2006-0661. The attack may be performed from remote. There is no available exploit.
Details
A vulnerability was found in Scriptme SmE GB Host 1.21 and classified as problematic. Affected by this issue is some unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-80. The product receives input from an upstream component, but it does not neutralize or incorrectly neutralizes special characters such as "<", ">", and "&" that could be interpreted as web-scripting elements when they are sent to a downstream component that processes web pages. Impacted is integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in Scriptme SmE GB Host 1.21 and SmE Blog Host allows remote attackers to inject arbitrary web script or HTML via the BBcode url tag.
The weakness was presented 02/13/2006 by Aliaksandr Hartsuyeu (Website). The advisory is shared for download at vupen.com. This vulnerability is handled as CVE-2006-0661 since 02/13/2006. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
It is declared as highly functional.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
The vulnerability is also documented in the databases at X-Force (24543), SecurityFocus (BID 16585†) and Secunia (SA18786†). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.2
VulDB Base Score: 4.3
VulDB Temp Score: 4.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-80 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/10/2006 🔍02/10/2006 🔍
02/13/2006 🔍
02/13/2006 🔍
02/13/2006 🔍
03/12/2015 🔍
08/06/2017 🔍
Sources
Advisory: vupen.com⛔Researcher: Aliaksandr Hartsuyeu
Status: Not defined
CVE: CVE-2006-0661 (🔍)
GCVE (CVE): GCVE-0-2006-0661
GCVE (VulDB): GCVE-100-28688
X-Force: 24543 - SmE GB Host and SmE Blog Host BBcode cross-site scripting
SecurityFocus: 16585 - Multiple Scriptme Applications BBCode URL Tag Script Injection Vulnerability
Secunia: 18786 - SmE GB Host / Blog Host "url" BBcode Script Insertion, Moderately Critical
Vupen: ADV-2006-0504
Entry
Created: 03/12/2015 11:11Updated: 08/06/2017 14:28
Changes: 03/12/2015 11:11 (50), 08/06/2017 14:28 (8)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.